AARP highlighted the BASHIR™ Endovascular Catheter (THROMBOLEX, Inc.), invented at the Lewis Katz School of Medicine at Temple University and developed by Thrombolex Inc., in its “Medical Breakthroughs” series. The catheter was approved by the U.S. Food and Drug Administration (FDA) for the treatment of acute pulmonary embolism back in the spring. Riyaz Bashir, MD, FACC, Director of Vascular and Endovascular Medicine at Temple University Hospital, is co-inventor of the BASHIR™ Endovascular Catheter and was interviewed for the AARP article.
IMPORTANT: Beginning at 8:00 AM on July 22, Temple University Hospital – Main Campus (Broad and Ontario Streets) will no longer provide Labor and Delivery services. All childbirth services will be relocated to our new hospital location.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH